Lineage Cell Therapeutics Inc. — Director's Dealing 2012

Jul 3, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOTIME INC (BTX)
CIK: 0000876343
Period of Report: 2012-07-01

Reporting Person: KINGSLEY ALFRED D (Director, See Remarks, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-07-01	Option to Puchase Common Shares	$4.60	A	50000	Acquired	2017-06-30	Common Shares (50000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to Puchase Common Shares	$5.13	2016-06-30	Common Shares (50000)	50000	Direct
Option to Puchase Common Shares	$5.45	2015-08-09	Common Shares (50000)	50000	Direct
Option to Puchase Common Shares	$2.30	2014-07-01	Common Shares (50000)	50000	Direct

Footnotes

F1: 12,500 options will become exercisable on September 30, 2012; December 31, 2012; March 31, 2013; and June 30, 2013 based upon continued service on the board of directors.

F2: 12,500 options became exercisable on September 30, 2011; December 31, 2011; March 31, 2012; and June 30, 2012.

F3: 12,500 options became exercisable on September 30, 2010; December 31, 2010; March 31, 2011; and June 30, 2011.

F4: 12,500 options became exercisable on September 30, 2009; December 31, 2009; March 31, 2010; and June 30, 2010.